TMCnet News

Diagnos Updates on Changes to Its Board [Manufacturing Close - Up]
[July 30, 2014]

Diagnos Updates on Changes to Its Board [Manufacturing Close - Up]


(Manufacturing Close - Up Via Acquire Media NewsEdge) Diagnos reported the appointment of Lloyd M. Segal and Michael Singer as Directors of the Corp. following the resignations of Rich Baxter and Bruno Maruzzo.

In its release, the Company said that Segal is Managing Partner at Persistence Capital Partners ("PCP"), Canada's private equity fund exclusively focused on high-growth opportunities in Canadian healthcare.

Segal is responsible for all aspects of PCP's investments from sourcing, evaluating and executing on investment opportunities, to managing existing investments. Segal has previously served as a director of several public and private corporations in the U.S. and Canada.



Singer is a Pharmaceutical industry Chief Financial Officer and consultant with senior level experience in both public and private life science technology companies. Prior to joining Diagnos, Singer served as Chairman of the board of Directors of Warnex. On July 8, Warnex was amalgamated with a subsidiary of Diagnos.

Diagnos is a company focusing on healthcare technical services.


More information and complete details: www.diagnos.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved.

[ Back To TMCnet.com's Homepage ]